InspireMD Statistics
Total Valuation
InspireMD has a market cap or net worth of $81.78 million. The enterprise value is $21.75 million.
Important Dates
The last earnings date was Tuesday, November 4, 2025, before market open.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
InspireMD has 42.37 million shares outstanding. The number of shares has increased by 47.64% in one year.
| Current Share Class | 42.37M |
| Shares Outstanding | 42.37M |
| Shares Change (YoY) | +47.64% |
| Shares Change (QoQ) | +44.04% |
| Owned by Insiders (%) | 21.71% |
| Owned by Institutions (%) | 30.88% |
| Float | 22.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.91 |
| Forward PS | 6.56 |
| PB Ratio | 1.26 |
| P/TBV Ratio | 1.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.80 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.51, with a Debt / Equity ratio of 0.05.
| Current Ratio | 6.51 |
| Quick Ratio | 6.09 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -87.61% and return on invested capital (ROIC) is -53.26%.
| Return on Equity (ROE) | -87.61% |
| Return on Assets (ROA) | -45.46% |
| Return on Invested Capital (ROIC) | -53.26% |
| Return on Capital Employed (ROCE) | -69.32% |
| Revenue Per Employee | $90,453 |
| Profits Per Employee | -$537,198 |
| Employee Count | 86 |
| Asset Turnover | 0.12 |
| Inventory Turnover | 1.93 |
Taxes
In the past 12 months, InspireMD has paid $59,000 in taxes.
| Income Tax | 59,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.89% in the last 52 weeks. The beta is 0.68, so InspireMD's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | -26.89% |
| 50-Day Moving Average | 2.23 |
| 200-Day Moving Average | 2.49 |
| Relative Strength Index (RSI) | 45.50 |
| Average Volume (20 Days) | 200,305 |
Short Selling Information
The latest short interest is 117,732, so 0.28% of the outstanding shares have been sold short.
| Short Interest | 117,732 |
| Short Previous Month | 114,950 |
| Short % of Shares Out | 0.28% |
| Short % of Float | 0.51% |
| Short Ratio (days to cover) | 1.72 |
Income Statement
In the last 12 months, InspireMD had revenue of $7.78 million and -$46.20 million in losses. Loss per share was -$0.82.
| Revenue | 7.78M |
| Gross Profit | 1.94M |
| Operating Income | -46.90M |
| Pretax Income | -46.14M |
| Net Income | -46.20M |
| EBITDA | -46.49M |
| EBIT | -46.90M |
| Loss Per Share | -$0.82 |
Full Income StatementBalance Sheet
The company has $63.40 million in cash and $3.37 million in debt, giving a net cash position of $60.03 million or $1.42 per share.
| Cash & Cash Equivalents | 63.40M |
| Total Debt | 3.37M |
| Net Cash | 60.03M |
| Net Cash Per Share | $1.42 |
| Equity (Book Value) | 64.11M |
| Book Value Per Share | 1.53 |
| Working Capital | 59.58M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$32.51 million and capital expenditures -$1.58 million, giving a free cash flow of -$34.08 million.
| Operating Cash Flow | -32.51M |
| Capital Expenditures | -1.58M |
| Free Cash Flow | -34.08M |
| FCF Per Share | -$0.80 |
Full Cash Flow StatementMargins
| Gross Margin | 24.91% |
| Operating Margin | -602.87% |
| Pretax Margin | -593.14% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
InspireMD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -47.64% |
| Shareholder Yield | -47.64% |
| Earnings Yield | -56.49% |
| FCF Yield | -41.68% |
Analyst Forecast
The average price target for InspireMD is $4.50, which is 133.16% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.50 |
| Price Target Difference | 133.16% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 27, 2021. It was a reverse split with a ratio of 1:15.
| Last Split Date | Apr 27, 2021 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
InspireMD has an Altman Z-Score of -2.87 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.87 |
| Piotroski F-Score | 3 |
